GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (SHSE:688366) » Definitions » EV-to-EBITDA

Shanghai Haohai Biological Technology Co (SHSE:688366) EV-to-EBITDA : 23.36 (As of May. 04, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Haohai Biological Technology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shanghai Haohai Biological Technology Co's enterprise value is ¥12,132 Mil. Shanghai Haohai Biological Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥519 Mil. Therefore, Shanghai Haohai Biological Technology Co's EV-to-EBITDA for today is 23.36.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's EV-to-EBITDA or its related term are showing as below:

SHSE:688366' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.87   Med: 12.42   Max: 50.68
Current: 22.98

During the past 10 years, the highest EV-to-EBITDA of Shanghai Haohai Biological Technology Co was 50.68. The lowest was 5.87. And the median was 12.42.

SHSE:688366's EV-to-EBITDA is ranked worse than
72.73% of 462 companies
in the Biotechnology industry
Industry Median: 9.55 vs SHSE:688366: 22.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-04), Shanghai Haohai Biological Technology Co's stock price is ¥96.00. Shanghai Haohai Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.542. Therefore, Shanghai Haohai Biological Technology Co's PE Ratio for today is 37.77.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Shanghai Haohai Biological Technology Co EV-to-EBITDA Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co EV-to-EBITDA Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.21 10.88 8.97 8.29 6.09

Shanghai Haohai Biological Technology Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.44 6.90 11.98 6.09 7.83

Competitive Comparison of Shanghai Haohai Biological Technology Co's EV-to-EBITDA

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's EV-to-EBITDA falls into.



Shanghai Haohai Biological Technology Co EV-to-EBITDA Calculation

Shanghai Haohai Biological Technology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12131.747/519.243
=23.36

Shanghai Haohai Biological Technology Co's current Enterprise Value is ¥12,132 Mil.
Shanghai Haohai Biological Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥519 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haohai Biological Technology Co  (SHSE:688366) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Shanghai Haohai Biological Technology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=96.00/2.542
=37.77

Shanghai Haohai Biological Technology Co's share price for today is ¥96.00.
Shanghai Haohai Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.542.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Shanghai Haohai Biological Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (SHSE:688366) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co (SHSE:688366) Headlines

No Headlines